About 4,200,000 results
Open links in new tab
Amgen's Uplizna posts strong results in myasthenia gravis trial
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis …
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 …
Amgen Seeks Expanded US Approval For Autoimmune Disease …
FDA Approves New Therapy for Rare Disease Affecting Optic …
Inebilizumab Improved Outcomes Over Placebo in Phase 3 Trials …
Uplizna Treatment for NMOSD Shows Sustained Clinical Benefit …
Amgen reports success for eczema and myasthenia gravis …
UPLIZNA® (inebilizumab-cdon) | NMOSD Treatment
Amgen reports positive data from Phase III IgG4-RD treatment trial
- Some results have been removed